Additionally, we observed that G9a/GLP pharmacological inhibition markedly induced cell death in CLL cells, demonstrating the role of these methyltransferases as potential targets for treatment and progression control of CLL [80]. The gene discussed is EHMT2; the disease is B-cell chronic lymphocytic leukemia.